Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT04317534
Title Adjuvant Pembrolizumab vs Observation Following Curative Resection for Stage I Non-small Cell Lung Cancer (NSCLC) With Primary Tumors Between 1-4 cm
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Greg Durm, MD
Age Groups: adult | senior
Covered Countries USA

No variant requirements are available.